Screening for Lung Cancer
Edward F. Patz, Philip C. Goodman, Gerold Bepler · New England Journal of Medicine · 2000
Lung cancer is the leading cause of death from cancer among men and women in the United States. More people die each year of lung cancer than of colon, breast, and prostate cancer combined. Despite new diagnostic techniques, the overall five-year survival rates remain about 14 percent, and most patients still present with advanced disease.1 There has long been interest in screening to detect lung cancers when they are smaller and presumably at earlier and more curable stages, as witnessed by the support for previous screening trials using chest radiography and cytologic examination of sputum. Unfortunately, these studies failed to . . .
Cited by 599 works. doi:10.1056/nejm200011303432208
Authors
References
- Revisions in the International System for Staging Lung Cancer
- Cancer statistics, 1998
- Early Lung Cancer Action Project: overall design and findings from baseline screening
- Clinical Applications of Research on Angiogenesis
- Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.
- Mass screening for lung cancer with mobile spiral computed tomography scanner
- Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography.
- Screening for lung cancer. A critique of the mayo lung project
- The Mayo Lung Project for Early Detection and Localization of Bronchogenic Carcinoma: A Status Report
- Survival and Mortality from Lung Cancer in a Screened Population